We are live on
!
Find out more
CRC
Catawba River Capital Portfolio holdings
AUM
$223M
1-Year Est. Return
24.34%
This Fund
S&P 500
This Quarter
Est. Return
-0.54%
1 Year Est. Return
+24.34%
3 Year Est. Return
+89.48%
5 Year Est. Return
+91.16%
10 Year Est. Return
–
AUM
$165M
AUM Growth
-$6.4M
(-3.7%)
Cap. Flow
-$3.57M
Cap. Flow
% of AUM
-2.16%
Top 10 Holdings %
Top 10 Hldgs %
63.42%
Holding
20
New
1
Increased
14
Reduced
5
Closed
–
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Canadian Natural Resources
CNQ
|
+$7.1M |
| 2 |
SPDR Gold Trust
GLD
|
+$4.09M |
| 3 |
Full House Resorts
FLL
|
+$3.88M |
| 4 |
Cadre Holdings
CDRE
|
+$214K |
| 5 |
Custom Truck One Source
CTOS
|
+$196K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Regeneron Pharmaceuticals
REGN
|
+$6.96M |
| 2 |
Occidental Petroleum
OXY
|
+$6.58M |
| 3 |
Construction Partners
ROAD
|
+$6.31M |
| 4 |
Atkore
ATKR
|
+$176K |
| 5 |
iShares Gold Trust
IAU
|
+$4.95K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Industrials | 50.81% |
| 2 | Healthcare | 9.78% |
| 3 | Technology | 9.57% |
| 4 | Energy | 8.55% |
| 5 | Consumer Discretionary | 7.53% |
Similar funds
PCM
SPAS
TS
NWMP
GCM
OWG
CCM
SONJCPFA
Catawba River Capital's Q2 2024 Portfolio in Review
As of Q2 2024, Catawba River Capital held 20 positions worth $165M, down 3.7% from $172M the previous quarter. Its ten largest holdings account for 63% of the portfolio.
Catawba River Capital's Q2 2024 filing shows 1 new, 14 increased and 5 reduced positions. Its largest new stake was Canadian Natural Resources: 188,756 shares worth $6.72M. The largest sale was Regeneron Pharmaceuticals, an estimated $6.96M.
By sector, the portfolio is most concentrated in Industrials at 51% of assets, down from 54% a quarter earlier, followed by Healthcare and Technology.
- Catawba River Capital's largest Q2 2024 buy was Canadian Natural Resources: 188,756 shares worth $6.72M.
- Catawba River Capital added most to SPDR Gold Trust in Q2 2024, an estimated $4.09M increase.
- Catawba River Capital's biggest Q2 2024 reduction was Regeneron Pharmaceuticals, cutting an estimated $6.96M.
- Catawba River Capital's ten largest holdings make up 63% of its $165M portfolio in Q2 2024.
- Catawba River Capital opened 1 new position and closed 0 in Q2 2024.
- Catawba River Capital's portfolio value fell 3.7% quarter-over-quarter to $165M.
Based on Catawba River Capital's 13F filing for Q2 2024, filed 12 Aug 2024.